ONO PHARMA USA, INC.

To identify and develop innovative and breakthrough
pharmaceutical products for diseases that remain
unconquered as yet

Creating new medicine
that challenges conventional wisdom

Only Ono

We believe there are challenges
only we can take on.

NewsList

May 10, 2023Company: Ono Pharmaceutical Co., Ltd. Announced 2022 Full Year Financial Results

April 18, 2023Company: ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLabs

March 22, 2023R & D: ONO PHARMA USA’s Tirabrutinib Receives Orphan Drug Designation from the FDA for the Treatment of Primary Central Nervous System Lymphoma

List

About

We Want to Deliver New Drugs
to the World with a Wish.

Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.

About

Priority Areas

Oncology
Immunology
Neurology
Specialty

Based on our unique drug discovery "Compound-Orient" approach finding diseases against which the properties of compounds are
most potentially effective, we have identified the therapeutic areas with high medical needs as our priority areas of research
to develop new drugs that will provide new treatment options with innovation to the frontline of healthcare. For this,
we will strengthen and enhance research and drug discovery alliance with world-leading universities, research institutes,
and biopharmaceutical companies in specific research areas. We will also drive forward activities in areas with great medical needs,
by in-licensing innovative compounds and acquiring novel technologies.

Learn More